Browse diseases

…of poor health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE) in Lupus Low Disease Activity State (LLDAS) or Definition…

…n anti-C1q levels and a greater proportion of abnormal results. SLE subtypes showed the highest detection rate of abnormal anti-C1q…

…included pharmacokinetics (PK) and clinical response. Change in lupus biomarkers, including interferon gene signature (IFN-GS), was a…

…th-related bodily pain among African American women living with systemic lupus erythematosus (SLE). However, there is a lack of evidence to describe the int…

…actory haemolytic anaemia This patient had a 10-year history of systemic lupus erythematosus (SLE), initially presenting with fatigue, polyarthritis, malar …

…al. Dapirolizumab pegol demonstrated significant improvement in systemic lupus erythematosus disease activity: efficacy and safety results of a phase 3 tria…

…rship (OR 0.23, 95% CI 0.10 to 0.51, p≤0.001).Conclusions Among SLE patients in remission, two distinct health-related quality of l…

…ourse, often leading to permanent organ damage. Childhood-onset SLE (cSLE) tends to be more aggressive with increased organ involve…

… a key determinant of poor prognosis and increased mortality in systemic lupus erythematosus (SLE). However, no validated clinical tools for predicting dama…

…blinded to patients’ responses, assessed disease activity using SLE Disease Activity Index 2000 (SLEDAI-2K) and Physician Global As…

…). However, data on immunogenicity of sequential vaccination in SLE are limited.Methods Adult patients with SLE (American College o…

…ported by a Clinical Decision Support System (CDSS), in routine SLE outpatient care.Methods A 24-week, non-randomised, multicentre,…